Corvex Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
-$10.68next fiscal year
Monitoring Framework
Key Performance Indicators
AI Platform and Services Revenue Quarterly475KTarget: Scale AI cloud computing platform and secure high-performance GPU-accelerated infrastructure workloads
Total Reported Revenue Quarterly510KTarget: Expand top-line performance post-merger with Corvex OpCo
Cash and Cash Equivalents Quarterly29.3MTarget: Maintain adequate liquidity to fund operations into the next fiscal year
Watch Items
- Stockholder Approval of Series C and Series D Preferred Stock ConversionTrigger: Vote outcome at the virtual Annual Meeting on June 22, 2026Action: Monitor proxy voting results for the Conversion Proposal to issue up to 68.6 million common shares upon conversion of Series C and D preferred stock
- Nasdaq Listing ComplianceTrigger: Regaining compliance with the minimum stockholders' equity requirement of $2.5 millionAction: Track post-merger balance sheet adjustments; stockholders' equity rose to $576.0 million as of March 31, 2026, resolving the previous delisting risk
- Legacy Healthcare Asset MonetizationTrigger: Sale or licensing of legacy medical device operations (EvieMED Ring and mmWave RF technology)Action: Monitor management's efforts to market and sell legacy healthcare assets to concentrate capital on AI infrastructure
Research as of 20 Jun 2026